【摘要】：目的:觀察代綜方顆粒治療代謝綜合征(metabolic syndrome,MS)糖脂代謝紊亂的臨床安全性和有效性。方法:采用自身前后對(duì)照的方法,給予MS患者代綜方配方顆粒劑治療8周。治療前后分別觀察血尿常規(guī)、肝腎功能、心電圖、肝臟超聲及腰圍、體重指數(shù)、血糖、血脂、血壓、空腹胰島素、空腹c肽和中醫(yī)臨床癥狀。填寫病例觀察表,錄入epidata數(shù)據(jù)庫(kù),復(fù)核數(shù)據(jù)剔除不合格病例,SPSS 17.0統(tǒng)計(jì)分析。結(jié)果:(1)完成45例,脫落1例、不合格6例,共38例納入統(tǒng)計(jì)分析;(2)體重、腰圍、體質(zhì)指數(shù)(BMI)較療前降低(P0.001);(3)改善血糖異常,空腹血糖(FBG)、餐后2 h血糖(PBG-2h)、糖化血紅蛋白(Hb A1c)較治療前降低(P0.001);(4)改善MS患者胰島素抵抗水平,增加胰島素敏感性指數(shù)(ISI)(P0.05);(5)改善血脂異常,甘油三酯(TG)、膽固醇(TC)、低密度脂蛋白(LDL-C)較療前降低,高密度脂蛋白(HDL-C)升高;(6)治療后高血壓患者血壓降低(P0.001);(7)治療后臨床癥狀、體征改善明顯,證候積分改善有效率為97.37%;(8)治療前后比較,安全性指標(biāo)未見(jiàn)異常。結(jié)論:代綜方顆粒能夠降低代謝綜合征高血糖、高血脂患者的血糖血脂水平,改善代謝紊亂,安全有效。
[Abstract]:Objective: to observe the clinical safety and efficacy of Daizhuangfang granule in the treatment of glucose and lipid metabolic disorder in metabolic syndrome (MS). Methods: the patients with MS were treated with comprehensive prescription granules for 8 weeks. Blood routine, liver and kidney function, electrocardiogram, liver ultrasound and waist circumference, body mass index, blood glucose, blood lipid, blood pressure, fasting insulin, fasting c-peptide and clinical symptoms of TCM were observed before and after treatment. Fill out the case observation form, input into the epidata database, and check the data to eliminate the unqualified cases and the statistical analysis of SPSS 17.0. Results: (1) 45 cases were completed, 1 case was lost, 6 cases were not qualified, 38 cases were included in statistical analysis, (2) body weight, waist circumference and body mass index (BMI) decreased compared with those before treatment (P0. 001); (3). Fasting blood glucose (FBG),) 2 h postprandial blood glucose (PBG-2h), glycosylated hemoglobin (HbA1c) decreased compared with pre-treatment (P0.001); (4) to improve insulin resistance in MS patients, and increased insulin sensitivity index (ISI) (P0.05); (5) to improve dyslipidemia. Triglyceride (TG), cholesterol (TC), low density lipoprotein (LDL-C) was lower and high density lipoprotein (HDL-C) was higher than that before treatment. (6) after treatment, the clinical symptoms and signs of hypertension patients decreased significantly after treatment (P0.001); (7). The effective rate of syndromes integral improvement was 97.37. (8) there was no abnormal safety index before and after treatment. Conclusion: Daizhuofang granule can reduce hyperglycemia and hyperlipidemia in patients with metabolic syndrome, improve metabolic disorder, and be safe and effective.
【作者單位】： 中國(guó)中醫(yī)科學(xué)院廣安門醫(yī)院;保定市第一中醫(yī)院;南京市中醫(yī)院;北京市密云縣河南寨社區(qū);
【基金】：國(guó)際科技合作項(xiàng)目(2010DFA31620) 科技部重大新藥創(chuàng)制項(xiàng)目(2011ZX09102-011-08)
【分類號(hào)】：R259

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 ;中醫(yī)藥防治代謝綜合征高峰論壇暨高級(jí)研修班征文通知[J];遼寧中醫(yī)雜志;2010年04期

2 龍新勝;鄭曉東;;淺析代謝綜合征的中西醫(yī)病因病機(jī)[J];天津中醫(yī)藥;2008年01期

3 張媛;李軍;;淺談代謝綜合征與腦卒中的相關(guān)性[J];陜西中醫(yī);2009年02期

4 陳建鴻;王建軍;;代謝綜合征虛 實(shí)證型患者血管內(nèi)皮功能變化的臨床研究[J];中華中醫(yī)藥學(xué)刊;2009年07期

5 楊慰;吳志宏;益敏輝;金國(guó)華;居海寧;夏靜雯;;中醫(yī)藥對(duì)代謝綜合征的認(rèn)識(shí)及治療進(jìn)展[J];中華中醫(yī)藥學(xué)刊;2014年07期

6 齊紅敏;郭宏敏;;老年代謝綜合征的危險(xiǎn)因素及中醫(yī)藥防治概況[J];山東中醫(yī)雜志;2014年07期

7 李勤;;代謝綜合征的中醫(yī)藥研究進(jìn)展[J];世界中醫(yī)藥;2014年05期

8 彭扣芝;馮志海;;代謝綜合征中醫(yī)防治思路[J];中外醫(yī)療;2010年16期

9 張惠敏;王濟(jì);李玲孺;;對(duì)痰濕體質(zhì)人群進(jìn)行健康管理是預(yù)防代謝綜合征的新思路[J];上海中醫(yī)藥雜志;2013年09期

10 林敏,彭礴,李p，

本文編號(hào)：2193315